Clinical Trial Update: Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results are reported for a chemoradiation regimen including cetuximab and pemetrexed with or without bevacizumab in locally advanced head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04